cefoperazone has been researched along with Disease Models, Animal in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (25.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Beger, RD; Carlson, PE; Cowley, SC; Foss, ED; Gasparyan, L; Giordano, NP; Hastie, JL; McMichael, HL; Prasad, D; Schubert, AM; Simonyan, V; Smith, AD; Sun, J; VinhNguyen, LP; Zhang, I | 1 |
| Antonopoulos, DA; Chang, EB; Frith, M; Kennedy, M; Koval, JC; Lee, STM; Leone, V; Miyoshi, J; Miyoshi, S; Puertolas, M | 1 |
| Du, L; Long, Y; Shi, H; Shi, L; Sun, L; Wang, H; Xu, H; Zhen, Y; Zhu, J; Zou, B | 1 |
| Cai, Y; Wang, J; Wang, R; Yang, D | 1 |
| Guinan, J; Thangamani, S | 1 |
| Falkowski, NR; Frank, CR; Huffnagle, GB; McDermott, AJ; McDonald, RA; Young, VB | 1 |
| Montgomery, SA; Thanissery, R; Theriot, CM; Winston, JA | 1 |
| Tuğrul, HM; Yıldırım, MI | 1 |
| Falkowski, NR; Huffnagle, GB; McDonald, RA; McKenzie, AN; Noverr, MC | 1 |
| He, Y; Liu, CH; Wang, LJ; Yang, XQ | 1 |
| Anderson, JC; Craven, N | 1 |
| Ciebieda, I; Denys, A; Ferszt, T; Korczak, E | 1 |
| Fasching, CE; Gerding, DN; Moody, JA; Peterson, LR; Sinn, LM | 1 |
| Barza, M; Davey, P; Peckman, C | 1 |
| Bonner, DP; Clark, JM; Fernandes, PB; Kao, CC; Sykes, RB; Weinberg, DS | 1 |
| Norrby, SR | 1 |
16 other study(ies) available for cefoperazone and Disease Models, Animal
| Article | Year |
|---|---|
Microbiota of MR1 deficient mice confer resistance against Clostridium difficile infection.
Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Clostridium Infections; Disease Models, Animal; Disease Resistance; Fecal Microbiota Transplantation; Feces; Gastrointestinal Microbiome; Histocompatibility Antigens Class I; Humans; Intestinal Mucosa; Mice; Mice, Knockout; Minor Histocompatibility Antigens; Mucosal-Associated Invariant T Cells; Specific Pathogen-Free Organisms | 2019 |
Metagenomic Alterations in Gut Microbiota Precede and Predict Onset of Colitis in the IL10 Gene-Deficient Murine Model.
Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Colitis; Disease Models, Animal; Dysbiosis; Feces; Female; Gastrointestinal Microbiome; Humans; Interleukin-10; Intestinal Mucosa; Male; Metagenome; Metagenomics; Mice; Mice, Knockout; Prognosis | 2021 |
Effects of specific egg yolk immunoglobulin on pan-drug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Cefoperazone; Dexamethasone; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Egg Yolk; Enzyme-Linked Immunosorbent Assay; Immunoglobulins; Injections, Intraperitoneal; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Pneumonia, Bacterial; Sulbactam; Tumor Necrosis Factor-alpha | 2017 |
Amikacin and cefoperazone/sulbactam alone or in combination against carbapenem-resistant Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Luminescent Measurements; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sulbactam | 2018 |
Antibiotic-induced alterations in taurocholic acid levels promote gastrointestinal colonization of Candida albicans.
Topics: Animals; Anti-Bacterial Agents; Candida albicans; Candidiasis; Cefoperazone; Cell Adhesion; Cell Line; Cholagogues and Choleretics; Colony Count, Microbial; Disease Models, Animal; Feces; Gastrointestinal Tract; Humans; Mice; Taurocholic Acid | 2018 |
Role of GM-CSF in the inflammatory cytokine network that regulates neutrophil influx into the colonic mucosa during Clostridium difficile infection in mice.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Cefoperazone; Clostridioides difficile; Clostridium Infections; Colon; Cytokines; Disease Models, Animal; Granulocyte-Macrophage Colony-Stimulating Factor; Intestinal Mucosa; Male; Mice, Inbred C57BL; Neutrophils | 2014 |
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291.
Topics: Animals; Anti-Bacterial Agents; Cefoperazone; Clostridioides difficile; Disease Models, Animal; Humans; Mice; Mice, Inbred C57BL | 2016 |
[Assessment of efficacies of imipenem, cefoperazone-sulbactam and cefepime in rats with experimental thigh abscess model with multidrug resistant and susceptible Acinetobacter baumannii strains].
Topics: Abscess; Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Cefepime; Cefoperazone; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Imipenem; Random Allocation; Rats; Rats, Wistar; Serum Bactericidal Test; Soft Tissue Infections; Sulbactam; Thigh | 2011 |
Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: role of host genetics, antigen, and interleukin-13.
Topics: Animals; Antigens; Candida albicans; Cefoperazone; Disease Models, Animal; Female; Gastrointestinal Tract; Interleukin-13; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Respiratory Hypersensitivity | 2005 |
[Allergic airway response associated with the intestinal microflora disruption induced by antibiotic therapy].
Topics: Animals; Anti-Bacterial Agents; Antibiosis; Aspergillus fumigatus; Asthma; Bronchoalveolar Lavage Fluid; Cefoperazone; Disease Models, Animal; Eosinophils; Female; Hypersensitivity; Hypersensitivity, Immediate; Intestines; Lung; Mice; Mice, Inbred BALB C; Ovalbumin; Respiratory System | 2007 |
Assessment in the mouse of cefoperazone as a treatment for mastitis.
Topics: Animals; Bacterial Infections; Cattle; Cefoperazone; Cloxacillin; Disease Models, Animal; Female; Kinetics; Mammary Glands, Animal; Mastitis; Mastitis, Bovine; Mice; Pregnancy; Staphylococcal Infections; Staphylococcus | 1984 |
[Effect of TFX (Polfa) on the course of experimental bacterial infections in mice treated with ciprofloxacin, amikacin and cefoperazone].
Topics: Amikacin; Animals; Cefoperazone; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Escherichia coli Infections; Female; Male; Mice; Mice, Inbred BALB C; Staphylococcal Infections; Staphylococcus aureus; Thymus Extracts | 1992 |
Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefamandole; Cefoperazone; Cephalothin; Daptomycin; Disease Models, Animal; Female; Glycopeptides; Oxacillin; Peptides; Rabbits; Staphylococcal Infections; Sulbactam; Teicoplanin; Vancomycin | 1990 |
Spontaneous inhibition of bacterial growth in experimental gram-negative endophthalmitis.
Topics: Animals; Cefoperazone; Disease Models, Animal; Endophthalmitis; Gentamicins; Hydrogen-Ion Concentration; Klebsiella Infections; Klebsiella pneumoniae; Male; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Rats; Rats, Inbred Strains; Skin; Vitreous Body | 1987 |
Evaluation of aztreonam, cefoperazone, latamoxef and ceftazidime in the hamster colitis model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; Bacterial Toxins; Cecum; Cefoperazone; Ceftazidime; Clindamycin; Colitis; Cricetinae; Disease Models, Animal; Drug Evaluation; Injections, Intraperitoneal; Male; Mesocricetus; Moxalactam | 1986 |
Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime.
Topics: Adult; Animals; Bacterial Infections; Cefoperazone; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Disease Models, Animal; Humans; Meningitis | 1985 |